Hal Burstein News Today

Breast density is known to naturally decrease as a woman ages, and now a study suggests that the more time it takes for breast density to decline, the more likely

Breast density is known to naturally decrease as a woman ages, and now a study suggests that the more time it takes for breast density to decline, the more likely

Breast density is known to naturally decrease as a woman ages, and now a study suggests that the more time it takes for breast density to decline, the more likely

Experts weighed in on the most significant research on triple-negative breast cancer from this years San Antonio Breast Cancer Symposium.

MONDAY, June 6, 2022 (HealthDay News) -- Two "smart bomb" drugs are offering new hope to women with aggressive breast cancers, a pair of clinical trials show.

High-profile breast cancer specialist Eric Winer, MD, has been named director of the Yale Cancer Center Yale Cancer Center.

The CDK4/6 inhibitor abemaciclib (Verzenio) has been approved for use in early breast cancer for certain patients who are at high risk for recurrence.